Evidence map›Paper›PMID 42604554›Full record

ArticleAngewandte Chemie (International ed. in English)2026

A Modular Synthesis of C5-Sulfenyl Thiazoles via an Intermolecular Pummerer Rearrangement: An Underexplored Scaffold for Medicinal Chemistry.

Joe L Smy, Theo C Webb, Barnaby W Greenland, S Mark Roe, John Spencer, Storm Hassell-Hart

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joe L SmyDepartment of Chemistry, School of Life Sciences, University of Sussex, Brighton, UK.ORCID https://orcid.org/0009-0006-3808-5240
Theo C WebbDepartment of Chemistry, School of Life Sciences, University of Sussex, Brighton, UK.ORCID https://orcid.org/0009-0009-4660-8314
Barnaby W GreenlandDepartment of Chemistry, School of Life Sciences, University of Sussex, Brighton, UK.ORCID https://orcid.org/0000-0002-8416-4955
S Mark RoeDepartment of Biochemistry, School of Life Sciences, University of Sussex, Brighton, UK.ORCID https://orcid.org/0000-0002-7371-9855
John SpencerDepartment of Chemistry, School of Life Sciences, University of Sussex, Brighton, UK.ORCID https://orcid.org/0000-0001-5231-8836
Storm Hassell-HartDepartment of Chemistry, School of Life Sciences, University of Sussex, Brighton, UK.ORCID https://orcid.org/0000-0001-6511-6037

Funding

EPSRC EP/X013332/1
6 · The paper itself

Abstract

The introduction of sulfur substituents to heterocyclic cores in fragments and drugs is hugely advantageous, improving key pharmacokinetic properties, providing additional vectors for synthetic elaboration, and potentially enhancing binding affinities. Despite this potential and their prevalence in drug discovery, sulfur-substituted thiazole scaffolds remain largely underexplored due to synthetic challenges in their preparation. To overcome the limitations in accessing these motifs, we report a mild, modular strategy for assembling C5-sulfenyl thiazoles from β-keto sulfoxides via an intermolecular Pummerer rearrangement. This methodology displays an excellent functional group tolerance, furnishing 50 diverse thiazole scaffolds derived from both thioamides and thioureas. The synthetic and medicinal impact of this methodology is showcased in the preparation and evaluation of thioether, sulfoxide and sulfone analogues of the blockbuster β3-adrenoceptor agonist mirabegron. Comparison of key pharmacokinetic properties revealed improved cell permeability, metabolic stability, lipophilicity and plasma protein binding without unduly affecting biological affinity relative to the parent drug.

Indexed as

ThiazolesAnimalsChemistry, PharmaceuticalHumansMolecular StructureThiazolesmedicinal chemistryPummerer rearrangementsulfur heterocyclesthiazolesthioether

Identifiers

PMID42604554
PMCPMC13638104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.